Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$177.05
-0.3%
$175.59
$163.33
$251.99
$50.92B0.252.06 million shs3.28 million shs
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$73.02
+0.3%
$76.13
$65.00
$112.38
$14.56B0.991.71 million shs3.40 million shs
Hologic, Inc. stock logo
HOLX
Hologic
$65.30
0.0%
$60.31
$51.90
$84.67
$14.56B0.552.37 million shs2.28 million shs
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$74.48
$70.16
$60.56
$82.49
$9.07B0.871.72 million shs1.45 million shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
+3.03%+3.44%+2.90%-21.64%-22.55%
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
+2.32%+2.65%+5.61%-10.37%-15.72%
Hologic, Inc. stock logo
HOLX
Hologic
+0.26%+0.77%+5.20%+7.88%-11.84%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
+1.96%+2.48%+6.61%+7.55%+14.39%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
4.7584 of 5 stars
3.23.03.34.02.22.51.3
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
3.518 of 5 stars
4.43.00.00.03.00.01.3
Hologic, Inc. stock logo
HOLX
Hologic
4.7768 of 5 stars
3.24.00.04.33.53.31.3
Henry Schein, Inc. stock logo
HSIC
Henry Schein
2.991 of 5 stars
1.31.00.03.42.81.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
2.36
Hold$219.2223.82% Upside
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
2.73
Moderate Buy$99.7036.54% Upside
Hologic, Inc. stock logo
HOLX
Hologic
2.41
Hold$77.4218.56% Upside
Henry Schein, Inc. stock logo
HSIC
Henry Schein
2.64
Moderate Buy$79.306.47% Upside

Current Analyst Ratings Breakdown

Latest BDX, COO, HOLX, and HSIC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/17/2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$100.00
6/17/2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeBuy
6/17/2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$94.00
6/3/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$261.00 ➝ $241.00
5/30/2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$107.00 ➝ $97.00
5/30/2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$115.00 ➝ $105.00
5/30/2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$118.00 ➝ $93.00
5/30/2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Neutral$110.00 ➝ $76.00
5/27/2025
Hologic, Inc. stock logo
HOLX
Hologic
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
5/22/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold$217.00 ➝ $185.00
5/22/2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
(Data available from 7/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$20.18B2.51$21.08 per share8.40$89.57 per share1.98
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$3.90B3.75$5.60 per share13.03$41.44 per share1.76
Hologic, Inc. stock logo
HOLX
Hologic
$4.03B3.61$5.50 per share11.88$22.09 per share2.96
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$12.67B0.72$7.33 per share10.16$32.33 per share2.30
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$1.71B$5.2412.6111.321.347.28%15.99%7.36%8/7/2025 (Estimated)
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$392.30M$2.0618.7616.411.7810.39%9.60%6.35%8/27/2025 (Estimated)
Hologic, Inc. stock logo
HOLX
Hologic
$789.50M$2.3715.8214.132.3913.83%19.71%10.87%8/4/2025 (Estimated)
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$390M$3.2015.5514.842.403.21%14.87%5.82%8/5/2025 (Estimated)

Latest BDX, COO, HOLX, and HSIC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/29/2025Q2 2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$0.93$0.96+$0.03$0.44$995.12 million$1.00 billion
5/5/2025Q1 2025
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$1.11$1.15+$0.04$0.88$3.24 billion$3.17 billion
5/1/2025Q2 2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$3.28$3.35+$0.07$1.06$5.35 billion$5.27 billion
5/1/2025Q2 2025
Hologic, Inc. stock logo
HOLX
Hologic
$1.02$1.03+$0.01-$0.08$1.00 billion$1.01 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$4.162.35%N/A79.39%53 Years
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
N/AN/AN/AN/AN/A
Hologic, Inc. stock logo
HOLX
Hologic
N/AN/AN/AN/AN/A
Henry Schein, Inc. stock logo
HSIC
Henry Schein
N/AN/AN/AN/AN/A

Latest BDX, COO, HOLX, and HSIC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/29/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
quarterly$1.042.02%6/9/20256/9/20256/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.70
1.13
0.64
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
0.30
2.10
1.23
Hologic, Inc. stock logo
HOLX
Hologic
0.54
3.24
2.52
Henry Schein, Inc. stock logo
HSIC
Henry Schein
0.50
1.38
0.75

Institutional Ownership

CompanyInstitutional Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
86.97%
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
24.39%
Hologic, Inc. stock logo
HOLX
Hologic
94.73%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
96.62%

Insider Ownership

CompanyInsider Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.36%
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
1.98%
Hologic, Inc. stock logo
HOLX
Hologic
1.88%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
1.08%
CompanyEmployeesShares OutstandingFree FloatOptionable
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
74,000286.61 million285.58 millionOptionable
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
16,000199.98 million196.02 millionOptionable
Hologic, Inc. stock logo
HOLX
Hologic
7,063222.85 million218.66 millionOptionable
Henry Schein, Inc. stock logo
HSIC
Henry Schein
25,000121.72 million120.41 millionOptionable

Recent News About These Companies

Henry Schein, Inc. (HSIC) - Yahoo Finance
Is Henry Schein Stock Outperforming the Dow?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Becton, Dickinson and Company stock logo

Becton, Dickinson and Company NYSE:BDX

$177.05 -0.62 (-0.35%)
Closing price 03:59 PM Eastern
Extended Trading
$176.47 -0.58 (-0.33%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Cooper Companies stock logo

Cooper Companies NASDAQ:COO

$73.02 +0.21 (+0.29%)
Closing price 04:00 PM Eastern
Extended Trading
$72.76 -0.26 (-0.36%)
As of 06:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Hologic stock logo

Hologic NASDAQ:HOLX

$65.30 -0.03 (-0.05%)
Closing price 04:00 PM Eastern
Extended Trading
$65.32 +0.03 (+0.04%)
As of 06:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Henry Schein stock logo

Henry Schein NASDAQ:HSIC

$74.48 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$74.48 +0.00 (+0.01%)
As of 06:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.